 This study aims to determine the efficacy and safety of QAW039 Dose 1 and Dose 2, compared with placebo, when added to GINA steps 4 and 5 standard-of- care SoC asthma therapy GINA 2015 in each of the groups patients with severe asthma and high eosinophil counts and all patients with severe asthma 